Industry
Cantourage UK and CannFX bring first New Zealand cannabis flower to UK
European cannabis company, Cantourage UK, is bringing the first-ever New Zealand medical cannabis flower to patients, thanks to a partnership with CannFX.
The New Zealand-based brand represents the majority of the country’s medical cannabis cultivators.
Its partnership with Cantourage UK will allow the company to import a variety of non-irradiated medical cannabis flowers that meet stringent quality and safety standards.
The partnership will also enable the development of new, innovative medical cannabis products that can meet the needs of patients.
Cantourage UK’s chief sales officer, Joshua Cuby, said: “We are thrilled to launch this partnership with New Zealand’s leading licensed cannabis exporter and to be able to offer our patients a new source of high-quality medical cannabis products.
“We are treating and learning from patients every day at Cantourage Clinic, we know that many patients are struggling to access indoor grown, high-quality medical cannabis flowers, and we believe that our partnership with CannFX will help address this issue.”
New Zealand is known for its high-quality agriculture, non-irradiated cannabis strains and well-regulated cannabis industry, making it an attractive location to produce medical cannabis.
By importing medical cannabis products from New Zealand, Cantourage UK hopes to provide patients with access to safe, effective treatments that they may not be able to find elsewhere.
CannFx’s indoor facility is expected to release more high-quality cultivars coming out of the agricultural epicentre of Australasia over the next few months.
“We believe that medical cannabis has the potential to transform the lives of millions of people around the world who are suffering from a range of medical conditions,” said Bastiaan Kramer, CEO of CannFX.
“By partnering with Cantourage UK, we are continuing to expand our international network to make NZ crafted medical cannabis more accessible to patients in need, wherever they may be.”
-
News6 months agoEurope’s first legal cannabis dispensaries to open under sixth Swiss pilot
-
Science5 months agoMedical cannabis doesn’t impair cognitive function – study
-
Industry6 months agoFirst Jersey-grown medicinal cannabis product to hit UK market
-
News6 months agoFive years of medical cannabis, five NHS prescriptions – how did we get here?
-
News5 months agoJapan takes major step towards cannabis reform
-
Health5 months agoUK data links medical cannabis to improvements in ADHD patients
-
News5 months agoMPs call for children with epilepsy to get medical cannabis on NHS
-
Health3 months agoUK researchers publish first findings on cannabis and Long COVID
